Comment on CMS-2026-1256-0002
Partnership to Fight Infectious DiseaseOpposeAdvocacy
Summary: The Partnership to Fight Infectious Disease (PFID) opposes the proposal to repeal the alternative pathway for New Technology Add-on Payment (NTAP) applications for Qualified Infectious Disease Products (QDIPS). They argue that the proposed change creates an impossible and unethical clinical trial standard for antibiotics and will stifle the development of new treatments needed to combat antibiotic resistance.
See attached file(s)